The nurse is assessing a client who is receiving digoxin. The nurse monitors for findings that would indicate an increased possibility of toxicity, such as:

Furosemide is a sulfonamide-derived loop diuretic that inhibits the sodium-potassium-chloride symporter in the thick ascending limb. It induces potent natriuresis and volume depletion to manage congestive heart failure and acute edema. Adverse effects include ototoxicity, hyperuricemia, and severe hypokalemia. It is contraindicated in patients with anuria or hepatic coma.

Rationale for correct answer

B. Furosemide causes a significant reduction in intravascular volume by promoting the excretion of sodium and water. This rapid fluid shift directly lowers systemic blood pressure and cardiac preload. The nurse must perform a pre-administration assessment to prevent the exacerbation of hypotension or circulatory collapse. Ensuring hemodynamic stability is a priority nursing intervention during diuretic therapy.

Rationale for incorrect answers

A. Patients receiving loop diuretics are at high risk for developing orthostatic hypotension due to decreased blood volume. Rapidly changing positions can lead to syncope, falls, and subsequent physical injury. Patients should be instructed to dangle their legs at the bedside before standing. This allows the baroreceptor reflex to adjust to the change in gravity and pressure.

C. Diuretics should be administered in the morning to prevent nocturia, which significantly disrupts the sleep-wake cycle. Administering a potent loop diuretic at bedtime increases the frequency of nighttime urination and elevates the risk for falls in older adults. Morning dosing ensures that the peak diuresis occurs during the patient's active waking hours.

D. Furosemide is a non-potassium-sparing agent that promotes significant renal excretion of potassium ions. Patients are at high risk for hypokalemia, not hyperkalemia, and must often increase their intake of potassium-rich fruits. Avoiding fruits would aggravate potassium depletion, potentially leading to lethal cardiac arrhythmias. Maintaining serum potassium between 3.5 and 5.0 mEq/L is essential for cardiac conduction.

Cardiac glycosides like digoxin inhibit the Na+/K+-ATPase pump, increasing intracellular calcium to enhance myocardial contractility. This narrow therapeutic index drug requires serum levels between 0.5 to 2.0 ng/mL. Toxicity precipitates life-threatening dysrhythmias, gastrointestinal distress, and profound neurological or sensory disturbances. Hypokalemia significantly increases the risk of digitalis toxicity.

Rationale for correct answers

A. Excessive levels of digoxin interfere with cerebral electrical activity and systemic hemodynamics. This neurotoxicity often manifests as significant dizziness or lightheadedness in the affected patient. It reflects the drug's impact on the central nervous system. The nurse must identify this as an early warning sign.

B. Digoxin toxicity frequently affects the cones of the retina and the optic nerve. Patients classically report visual changes such as xanthopsia or seeing yellow-green halos around lights. This is a hallmark sign of advanced glycoside accumulation. Immediate clinical evaluation and serum level checks are mandatory.

C. Neurological irritation from toxic levels of cardiac glycosides can trigger persistent discomfort. Severe headaches are documented as a common symptomatic manifestation of digitalis-induced neuralgia. This symptom often precedes more dangerous cardiac conduction blocks. Monitoring for these neurological changes is essential for safety.

Rationale for incorrect answers

D. Digoxin is used to improve cardiac output, which should theoretically support kidney perfusion and maintain urination. However, increased urine output is a therapeutic goal of diuretics, not a sign of glycoside toxicity. Toxicity is more likely to cause nausea, vomiting, or profound bradycardia. It does not manifest as a sudden diuresis.

E. The presence of melena or dark stools typically indicates upper gastrointestinal bleeding or iron supplementation. Digoxin toxicity causes anorexia and abdominal pain but does not cause gastrointestinal hemorrhage. This finding would suggest a different pathology entirely, such as a peptic ulcer. It is not associated with cardiac glycoside levels.

Test-taking strategy

• Identify the drug class and its risks: Digoxin has a very narrow therapeutic window, meaning the difference between a helpful dose and a toxic dose is small.
• Recall the "big three" of digoxin toxicity:
  • Gastrointestinal: Nausea, vomiting, anorexia.
  • Cardiac: Bradycardia, heart blocks, PVCs.
  • Neurological/Sensory: Confusion, headaches, dizziness, and the classic yellow-green halos (xanthopsia).
• Evaluate the options against these categories:
  • Options 1, 2, and 3 fit perfectly into the neurological and sensory categories.
• Rule out unrelated physiological effects:
  • Increased urine output (Option 4) is the goal of diuretics, which are often taken with digoxin but have a different toxicity profile.
  • Dark stools (Option 5) is a sign of bleeding or medication like iron/bismuth, not heart medication toxicity.
• Prioritize the "hallmark" sign: If you see "halos" or "yellow vision" in a digoxin question, it is almost always related to toxicity.

Take home points

• Digoxin toxicity often presents first with gastrointestinal symptoms like anorexia and nausea before progressing to neurological and cardiac signs.
• Visual disturbances, specifically seeing yellow-green halos around lights, are classic indicators of digoxin overdosage.
• Patients must be educated to report new-onset dizziness or headaches, as these can signal impending cardiac arrhythmias.
• Low serum potassium levels increase the risk of digoxin toxicity, so patients must maintain stable electrolyte balances during therapy.